MedPath

ltrasound Guided Suprascapular nerve block combined with intra-articular injection of bupivacaine versus ultrasound-guided interscalene nerve block in shoulder arthroscopy.

Not Applicable
Conditions
Anaesthesia
Registration Number
PACTR202308722616710
Lead Sponsor
Faculty of Medecine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Physical status: ASA I and II.
Age: between 21 and 60 years old.

Exclusion Criteria

Refusal of informed consent for regional anaesthesia.
Known Allergy to one of the study drugs.
History or evidence of coagulopathy, use of anti-coagulant, anti-platelet therapy, or infection at the injection site.
Patients with a history of drug abuse.
Patients with a history of upper limb neuronal injury at the same limb of the block.
Patients with history of respiratory distress for fear of diaphragmatic paralysis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure will be the time interval after which there will be a requirement of the first supplemental dose of rescue analgesia (Pethidine 50mg IM) with NRS =4.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome is the total dose of pethidine that will be received as rescue analgesia in 1st 24 hours postoperatively, hemodynamics and complications such as nausea, vomiting, and respiratory distress due to diaphragmatic paralysis assessed by chest ultrasound or pneumothorax assessed clinically and by A-P chest X-ray.
© Copyright 2025. All Rights Reserved by MedPath